Amneal Pharmaceuticals, Inc. (AMRX)

Amneal Pharmaceuticals Stock Forecast

Stock Price Forecast

The 5 analysts that cover Amneal Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $15.6, which forecasts a 13.70% increase in the stock price over the next year. The lowest target is $13 and the highest is $19.

Price Target: $15.6 (+13.70%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$13	$15.6	$15	$19
Change	-5.25%	+13.70%	+9.33%	+38.48%

Analyst Ratings

The average analyst rating for Amneal Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	0	0	0	0	1	2
Buy	3	4	4	4	4	3
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	4	4	4	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ashwani Verma UBS	UBS	Strong Buy Initiates $19	Strong Buy	Initiates	$19	+38.48%	Apr 17, 2026
Les Sulewski Truist Securities	Truist Securities	Strong Buy Maintains $15 → $17	Strong Buy	Maintains	$15 → $17	+23.91%	Mar 2, 2026
Glen Santangelo Barclays	Barclays	Buy Initiates $15	Buy	Initiates	$15	+9.33%	Dec 9, 2025
David Amsellem Piper Sandler	Piper Sandler	Buy Reiterates $11 → $13	Buy	Reiterates	$11 → $13	-5.25%	Oct 31, 2025
Chris Schott JP Morgan	JP Morgan	Buy Maintains $12 → $14	Buy	Maintains	$12 → $14	+2.04%	Sep 16, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

3.15B

Increased by 4.48%

from 3.02B

Revenue Next Year

3.38B

Increased by 7.13%

from 3.15B

EPS This Year

1.01

Increased by 359.00%

from 0.22

EPS Next Year

1.20

Increased by 18.79%

from 1.01

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	2.09B	2.21B	2.39B	2.79B	3.02B	3.15B	3.38B
Revenue Growth	5.08%	5.67%	8.20%	16.73%	8.05%	4.48%	7.13%
EPS	0.07	-0.86	-0.48	-0.38	0.22	1.01	1.20
EPS Growth	-88.52%	-	-	-	-	359.00%	18.79%
Forward PE	-	-	-	-	-	13.59	11.44
No. Analysts	-	-	-	-	-	7	7

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028
High	3.3B	3.5B
Avg	3.2B	3.4B
Low	3.0B	3.2B

Revenue Growth

Revenue Growth	2026	2027	2028
High	8.1%	11.4%
Avg	4.5%	7.1%
Low	-0.4%	1.2%

EPS Forecast

EPS	2026	2027	2028
High	1.05	1.28
Avg	1.01	1.20
Low	0.96	1.09

EPS Growth

EPS Growth	2026	2027	2028
High	377.3%	26.9%
Avg	359.0%	18.8%
Low	336.5%	7.7%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.